Clinical Trials Logo

Clinical Trial Summary

This study aims to develop and validate a sensitive and non-invasive eye-tracking software application.


Clinical Trial Description

This study will obtain participant responses to brief cognitive tests designed to evaluate several key functions known to be affected by the Cancer-related cognitive impairment (CRCI) and non-invasive eye movement measurements in response to visually presented stimuli during specifically designed eye-tracking tests. The study data will be used to develop machine learning algorithms and validate a software application intended to track the progressive component of the Cancer-related cognitive impairment (CRCI) and associated cognitive changes. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05186948
Study type Observational
Source Innodem Neurosciences
Contact Marianna Perna
Phone 514-934-1934
Email marianna.perna@muhc.mcgill.ca
Status Recruiting
Phase
Start date March 30, 2022
Completion date January 20, 2025

See also
  Status Clinical Trial Phase
Completed NCT05030792 - An Attention-Restorative Therapy (ART)-Based Virtual Reality Intervention to Address Cancer-Related Cognitive Impairments Among Breast Cancer Survivors N/A
Active, not recruiting NCT04565769 - Cognitive Function in Patients Treated for Metastatic Melanoma With Immune Checkpoint Inhibitors
Not yet recruiting NCT05855694 - Photobiomodulation for Cancer-Related Cognitive Impairment N/A
Recruiting NCT02661308 - Reducing Cancer Side-effects With Systematic Light Exposure N/A
Completed NCT03452436 - Testosterone, Cognition, Ageing, and Cancer
Completed NCT04667689 - An Online Cognitive Assessment in Cancer Patients N/A